CRP and depressive symptom measurement: Meta-analyses have shown that serum CRP levels are reliably elevated in MDD (Valkanova et al., 2013) and have been found to predict future development of depression as well as resistance to standard antidepressant therapies (Au et al., 2015, Chamberlain et al., 2019, Strawbridge et al., 2015).